Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 17 studies | 57% ± 19% | |
glutamatergic neuron | 10 studies | 40% ± 18% | |
GABAergic neuron | 10 studies | 44% ± 19% | |
interneuron | 5 studies | 58% ± 28% | |
oligodendrocyte precursor cell | 4 studies | 20% ± 3% | |
neuron | 3 studies | 31% ± 12% | |
endothelial cell | 3 studies | 34% ± 14% | |
GABAergic interneuron | 3 studies | 38% ± 16% | |
microglial cell | 3 studies | 21% ± 4% | |
GABAergic amacrine cell | 3 studies | 29% ± 6% | |
rod bipolar cell | 3 studies | 45% ± 20% | |
granule cell | 3 studies | 29% ± 6% | |
astrocyte | 3 studies | 31% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 36% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4837.81 | 2634 / 2642 | 70% | 3.83 | 496 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.46 | 1 / 1 |
adrenal gland | 2% | 5.22 | 4 / 258 | 18% | 1.11 | 42 / 230 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.94 | 5 / 29 |
esophagus | 3% | 12.40 | 47 / 1445 | 5% | 0.08 | 9 / 183 |
liver | 0% | 0 | 0 / 226 | 7% | 0.11 | 27 / 406 |
intestine | 4% | 17.46 | 40 / 966 | 0% | 0.00 | 1 / 527 |
adipose | 3% | 13.15 | 34 / 1204 | 0% | 0 | 0 / 0 |
skin | 0% | 0.75 | 3 / 1809 | 2% | 0.12 | 11 / 472 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.07 | 4 / 178 |
breast | 1% | 5.94 | 6 / 459 | 1% | 0.01 | 7 / 1118 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.04 | 9 / 504 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.03 | 8 / 459 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.02 | 4 / 286 |
lung | 0% | 0 | 0 / 578 | 1% | 0.02 | 16 / 1155 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
prostate | 1% | 3.47 | 2 / 245 | 0% | 0.00 | 1 / 502 |
ovary | 1% | 1.77 | 1 / 180 | 0% | 0 | 0 / 430 |
thymus | 0% | 0.49 | 1 / 653 | 0% | 0.00 | 2 / 605 |
muscle | 0% | 1.09 | 2 / 803 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 2 / 901 |
peripheral blood | 0% | 2.28 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_2000821 | Biological process | regulation of grooming behavior |
GO_0007155 | Biological process | cell adhesion |
GO_0032225 | Biological process | regulation of synaptic transmission, dopaminergic |
GO_0032228 | Biological process | regulation of synaptic transmission, GABAergic |
GO_0042995 | Cellular component | cell projection |
GO_0042734 | Cellular component | presynaptic membrane |
Gene name | CNTNAP4 |
Protein name | Contactin-associated protein-like 4 (Cell recognition molecule Caspr4) Contactin associated protein family member 4 |
Synonyms | CASPR4 KIAA1763 |
Description | FUNCTION: Presynaptic protein involved in both dopaminergic synaptic transmission and GABAergic system, thereby participating in the structural maturation of inhibitory interneuron synapses. Involved in the dopaminergic synaptic transmission by attenuating dopamine release through a presynaptic mechanism. Also participates in the GABAergic system (By similarity). . |
Accessions | A0A087WTA1 ENST00000307431.12 ENST00000377504.8 E9PDN6 ENST00000611870.5 [Q9C0A0-1] ENST00000478060.5 [Q9C0A0-2] F5H107 ENST00000476707.1 ENST00000622250.4 Q9C0A0 A0A0A0MR20 |